Lincoln National Corporation (LNC) and MetLife, Inc. (MET) are prominent players in the life insurance and annuities sector, making them natural comparables for investors navigating the financial services market. This stock comparison analyzes their recent performance, valuations, and market positioning amid evolving interest rate environments and economic shifts. Traders seeking value plays or income opportunities, as well as those monitoring insurance sector relative performance, will find insights into momentum, risk profiles, and growth drivers relevant for portfolio decisions.
Lincoln National Corporation (LNC) provides life insurance, annuities, and group protection products primarily in the U.S. In recent market activity, LNC shares have shown resilience, closing around $37.53 with a 52-week range of $31.61 to $46.82. The stock has gained 13.73% YTD, outperforming broader indices in recent weeks, driven by anticipation of earnings growth and a declared Series D preferred stock dividend. Key metrics include a trailing P/E ratio of 6.44, return on equity (ROE) of 12.28%, and market cap of $7.18 billion. Sentiment has been supported by analyst price targets averaging $42.58, though some firms like Bank of America recently lowered targets amid sector caution. Rising rates have bolstered net investment income (NII), aiding statutory profitability.
MetLife, Inc. (MET) is a global provider of life insurance, annuities, and employee benefits with significant international exposure. Recently, shares traded near $80.23 within a 52-week range of $67.33 to $83.85, posting modest YTD gains of 2.36%. A 4.4% dividend increase has underpinned income appeal, while upcoming Q1 earnings are expected to show EPS of $2.23 on $19.2 billion revenue. Valuation stands at a trailing P/E of 17.03, ROE of 12.02%, and market cap of $51.76 billion. Analyst targets average $89.31, with a Buy rating from Bank of America despite a lowered price target. Recent weeks reflect stability from higher investment income, though shares dipped post-Q4 results amid mixed premiums growth.
Tickeron's Trending AI Robots page curates 25 top-performing bots from over 351 AI trading systems that analyze thousands of tickers across diverse strategies and timeframes. These bots deliver real-time signals for copy trading, showcasing impressive stats like annualized returns from +23.53% to +163.10%, win rates of 51.30% to 88.33%, and profit factors up to 11.70. Examples include momentum-driven short-term bots with 49-day holds on penny stocks or swing traders targeting sectors like semiconductors and gold miners. Timeframes range from 1 day to several weeks, with drawdowns managed via take-profit/stop-loss rules. Ideal for current volatile conditions, these bots suit various styles from aggressive growth to conservative plays—explore them to enhance your trading edge.
Both LNC and MET operate multi-line insurance models focused on life products and annuities, benefiting from higher rates that lift NII and book values. However, MET's global scale drives broader revenue diversification, while LNC emphasizes U.S. retirement solutions. Recent momentum favors LNC with superior YTD returns and lower forward P/E, signaling value amid growth expectations. Risk profiles diverge: MET's lower beta and higher debt/equity (225.97%) reflect stability but leverage concerns, versus LNC's higher volatility and current ratio of 2.23. Market sentiment leans positive for both pre-earnings, with LNC cheaper on price/book (0.72 vs. 1.82) but MET stronger in absolute size.
Tickeron's AI models would currently lean toward LNC over MET, based on stronger trend consistency in recent months, undervalued forward metrics, and elevated yield supporting total returns. While MET offers defensive positioning, LNC's relative momentum and catalysts like earnings growth present higher probabilistic upside in the near term for balanced portfolios.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LNC’s FA Score shows that 1 FA rating(s) are green whileMET’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LNC’s TA Score shows that 4 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s).
LNC (@Life/Health Insurance) experienced а -2.19% price change this week, while MET (@Life/Health Insurance) price change was +3.09% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -0.78%. For the same industry, the average monthly price growth was -0.73%, and the average quarterly price growth was +8.15%.
LNC is expected to report earnings on Jul 30, 2026.
MET is expected to report earnings on Aug 05, 2026.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| LNC | MET | LNC / MET | |
| Capitalization | 6.56B | 52.2B | 13% |
| EBITDA | N/A | N/A | - |
| Gain YTD | -21.110 | 4.225 | -500% |
| P/E Ratio | 3.75 | 15.68 | 24% |
| Revenue | 18.9B | 76B | 25% |
| Total Cash | 34.8B | N/A | - |
| Total Debt | 6.37B | 20.2B | 32% |
LNC | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 63 | 9 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 11 Undervalued | 44 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 43 | |
SMR RATING 1..100 | 96 | 99 | |
PRICE GROWTH RATING 1..100 | 62 | 40 | |
P/E GROWTH RATING 1..100 | 73 | 30 | |
SEASONALITY SCORE 1..100 | 50 | 47 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LNC's Valuation (11) in the Life Or Health Insurance industry is somewhat better than the same rating for MET (44). This means that LNC’s stock grew somewhat faster than MET’s over the last 12 months.
MET's Profit vs Risk Rating (43) in the Life Or Health Insurance industry is somewhat better than the same rating for LNC (100). This means that MET’s stock grew somewhat faster than LNC’s over the last 12 months.
LNC's SMR Rating (96) in the Life Or Health Insurance industry is in the same range as MET (99). This means that LNC’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (40) in the Life Or Health Insurance industry is in the same range as LNC (62). This means that MET’s stock grew similarly to LNC’s over the last 12 months.
MET's P/E Growth Rating (30) in the Life Or Health Insurance industry is somewhat better than the same rating for LNC (73). This means that MET’s stock grew somewhat faster than LNC’s over the last 12 months.
| LNC | MET | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 65% |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 52% |
| Momentum ODDS (%) | 1 day ago 75% | 1 day ago 59% |
| MACD ODDS (%) | 1 day ago 76% | 1 day ago 60% |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 57% |
| TrendMonth ODDS (%) | 1 day ago 72% | 1 day ago 48% |
| Advances ODDS (%) | 15 days ago 71% | 3 days ago 62% |
| Declines ODDS (%) | 10 days ago 71% | 10 days ago 56% |
| BollingerBands ODDS (%) | 1 day ago 82% | 1 day ago 51% |
| Aroon ODDS (%) | 1 day ago 62% | 1 day ago 45% |
A.I.dvisor indicates that over the last year, LNC has been closely correlated with MET. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if LNC jumps, then MET could also see price increases.